Did you know that X-ray technology goes far beyond just medical diagnostics? X-ray tubes, which are vacuum tubes converting electrical power into powerful X-ray beams, are revolutionizing a range of industries.
While high-performance X-ray tubes drive innovation in healthcare — especially in areas like advanced CT scanning and angiography — their applications extend to remarkable fields like:
• 𝐀𝐞𝐫𝐨𝐬𝐩𝐚𝐜𝐞 𝐚𝐧𝐝 𝐃𝐞𝐟𝐞𝐧𝐬𝐞
• 𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐐𝐮𝐚𝐥𝐢𝐭𝐲 𝐂𝐨𝐧𝐭𝐫𝐨𝐥
• 𝐅𝐨𝐨𝐝 𝐚𝐧𝐝 𝐁𝐞𝐯𝐞𝐫𝐚𝐠𝐞 𝐒𝐚𝐟𝐞𝐭𝐲
• 𝐒𝐞𝐜𝐮𝐫𝐢𝐭𝐲 𝐚𝐧𝐝 𝐒𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠
And this is just the beginning!
Interested in learning more about how X-ray technology is transforming these diverse sectors in unprecedented ways?
Check out our latest blog, ‘𝐗-𝐑𝐚𝐲 𝐓𝐮𝐛𝐞 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐊𝐞𝐲 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬 𝐄𝐱𝐭𝐞𝐧𝐝𝐢𝐧𝐠 𝐁𝐞𝐲𝐨𝐧𝐝 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞,’ to explore the leading applications and cutting-edge advancements shaping the field of radiology.
Check Here: https://lnkd.in/dssn9rk9
Could the future of radiology redefine what’s possible, reaching far beyond diagnostics and inspections? Let’s talk in the comments!
And if this post sparks your interest, don’t forget to share it with others and leave us a like!
.
.
.
Canon Electronics Inc.Comet GroupGE HealthCareGulmay L.T.D.#xraytube#healthcare#diagnosticdevices#xraytechnology#radiology#diagnosticimaging#xraysystems#marketoverview#inkwoodresearch
Today, we announce an exciting milestone as Keysight Technologies (NYSE:KEYS) makes an AU$ 15.28 million strategic equity investment in EMVision Medical Devices , providing a fully funded commercial runway for our landmark emu™️ device.
emu™️ is a pioneering advancement in #stroke care, intended to provide rapid, portable diagnostic imaging in settings where traditional modalities — like CT and MRI — are not readily accessible. Targeted for use in ICUs, stroke and neurology wards, and rural emergency settings, emu™️ has the potential to considerably improve survival rates and quality of life after stroke and other neurological events.
"Keysight’s commitment to being at the frontline of #innovation aligns perfectly with our mission to make ubiquitous portable brain imaging a reality. The investment is a significant endorsement of our technology and we look forward to building on our strategic relationship," Scott Kirkland, CEO and Managing Director said.
Huei Sin Ee#MedicalDevice#TechWrapUpAU#EMVision $EMV #radiology
Full details of the ASX announcement can be viewed: https://lnkd.in/gh5PvVCy
We're making photonics part of everyday medical devices! 🩺⌚
💡 VTT is leading a €32M project with 39 partners across 9 countries to speed up the commercialisation of photonics-based medical devices, making healthcare tools more accurate, faster and less invasive.
💡 “Until now, the gap between research and manufacturing has been a major hurdle in introducing photonics innovations for medical applications. The PhotonMed project aims to bridge the gap by creating structured industrial supply chains and leveraging a pilot line R&D model to facilitate faster commercialisation,” says VTT’s Jussi Hiltunen.
Read more 👉 https://hubs.ly/Q02ZMyTj0#VTTBeyondTheObvious#healthcare#photonics
Their conclusion: To achieve organizational objectives in an ever-evolving landscape, imaging providers must develop strategies to meet increased demand for services, drive cost reduction and improve efficiencies. This starts with data-driven insights and intelligence.
...“Until now, the gap between research and manufacturing has been a major hurdle in introducing photonics innovations for medical applications. Coupled with regulatory validation processes, the time-to-market takes years, incurring high costs. The PhotonMed project aims to bridge the gap by creating structured industrial supply chains and leveraging a pilot line R&D model to facilitate faster commercialisation,” says VTT’s Research Professor Jussi Hiltunen."...
We're making photonics part of everyday medical devices! 🩺⌚
💡 VTT is leading a €32M project with 39 partners across 9 countries to speed up the commercialisation of photonics-based medical devices, making healthcare tools more accurate, faster and less invasive.
💡 “Until now, the gap between research and manufacturing has been a major hurdle in introducing photonics innovations for medical applications. The PhotonMed project aims to bridge the gap by creating structured industrial supply chains and leveraging a pilot line R&D model to facilitate faster commercialisation,” says VTT’s Jussi Hiltunen.
Read more 👉 https://hubs.ly/Q02ZMyTj0#VTTBeyondTheObvious#healthcare#photonics
What Will J&J, Abbott, and Intuitive Reveal?
As Q3 earnings reports roll in, we’re set to uncover insights into three fast-growing sectors: Pulsed Field Ablation, Diabetes Tech, and Surgical Robotics.
Johnson & Johnson: A complex picture unfolds.
• PFA Device: Still awaiting FDA approval—falling behind Boston Scientific and Medtronic in electrophysiology.
• Ottava Surgical Robot: FDA submission announced—setting the stage for future competition in robotic surgery by the decade's end.
Abbott: Strong performance across multiple segments.
• PFA Device: Progress towards market entry with Abbott’s own device remains crucial.
• Other Growth Areas: Positive trends in diabetes care, structural heart, and pacemakers.
Intuitive: Exceeding expectations.
• da Vinci 5: Successful rollout leading to increased placements and growth.
• Revenue Growth: 17% increase, fueled by robust procedure volume.
Despite challenges, the medtech landscape remains stable for these key players.
Which company’s innovations do you think will drive the biggest shifts in healthcare?
#MedTech#MedicalDevices#Electrophysiology#SurgicalRobotics#DiabetesTech#PFA#JohnsonAndJohnson#Abbott#IntuitiveSurgical
Detection Technology launches advanced X-ray detector portfolio at RSNA 2024
Detection Technology, a global leader in X-ray detector solutions, unveils a comprehensive portfolio of flat panel X-ray detectors at the RSNA 2024 exhibition to advance medical imaging.
via News Medical Device / Technology News Feed
We’re living in an era of groundbreaking advancements in catheter technology, with some of the world’s most innovative solutions being developed to treat a wide range of venous and vascular diseases.
Companies at the forefront of these advancements, including some of our past podcast guests, are leading the charge. Notable names such as LimFlow (now Inari Medical), FastWave Medical, and Amplitude Vascular Systems are pushing boundaries to deliver life-saving technologies.
While these innovations are transformative, a critical question remains: how can we enhance early diagnosis and patient monitoring in a way that’s simple, timely, and cost-effective?
Enter IntelVasc Inc., a company pioneering a minimally invasive sensor designed for subcutaneous insertion near the femoral artery. This sensor, paired with a portable scanner, empowers patients to monitor their vascular health from the comfort of their homes. By providing real-time data on blood flow, IntelVasc’s technology equips patients and clinicians with the tools to identify issues proactively and intervene early, reducing the risk of serious complications.
In this episode, Richard and I had the privilege of sitting down with IntelVasc’s CEO and Co-Founder, Andrew Ortega-Verdaguer. We explored the challenges of today’s diagnostic methods and how IntelVasc’s innovative approach has the potential to revolutionize vascular health monitoring and diagnosis.
Improving and saving lives - that's what it's all about!
🚀
#medicaldevice#medicaldevices#cardiology#cardiovascular
